The USFDA has scheduled a Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting on Tuesday, June 28, 2022 to discuss whether and how the SARS-CoV-2 strain composition of COVID-19 vaccines should be modified.
Back to All Events
Earlier Event: June 17
Psychopharmacologic Drugs Advisory Committee
Later Event: September 7
Peripheral and Central Nervous System Drugs Advisory Committee